Powerful Memory Enhancement
CogniCare Pro supports 6 different indicators of brain performance: focus, memory, learning, accuracy, concentration and reasoning
Improve Your Brain Performance
When I first started working on the formula that was to become CogniCare Pro, I never would have imagined in a million years that I would one day help support healthy brain function.
It’s people like you that make all those years of research and testing worthwhile, and I hope you manage to get the most out of CogniCare Pro while I can still afford to produce it at these prices.
Elizabeth Bennett - Creator, CogniCare Pro
Feel Great Enjoy Life
CogniCare Pro is a versatile brain booster supplement, not only enhances mood, focus, and healthy aging but also aids in fighting stress and anxiety while promoting accuracy, and calming the mind and body, allowing you to simply be you.
Scientific References
The company is not endorsed by, sponsored by, or affiliated with any of these organizations
- Chronic Inflammation Linked to Dementia – Alissa Sauer – 2018
- Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer’s disease – R Wang – 2005
- L-Carnitine Supplementation in Older Women. A Pilot Study on Aging Skeletal Muscle Mass and Function – AK Sawicka – 2018
- Reduced Alzheimer’s disease pathology by St. John’s wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice – J Hofrichter – 2013
- Effects of Tooth Loss and the Apolipoprotein E ɛ4 Allele on Mild Memory Impairment in the Fujiwara-kyo Study of Japan: A Nested Case-Control Study – N Okamoto – 2017
- Neuropsychological Training of Attention Improves MS-Related Fatigue: Results of a Randomized, Placebo-Controlled, Double-Blind Pilot Study – P Flachenecker – 2017
- Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical Studies – ASA Manap – 2019
- Reduced Alzheimer’s disease pathology by St. John’s wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice – J Hofrichter – 2013
- Role of Striatal-Enriched Tyrosine Phosphatase in Neuronal Function – M Kamceva – 2016
- In search for Alzheimer’s drug, a major STEP forward – KN Peart – 2014
- A common STEP in the synaptic pathology of diverse neuropsychiatric disorders – MA Johnson – 2012
- A STEP forward in neural function and degeneration – ML Baum – 2010
- Inhibitor of the tyrosine phosphatase STEP reverses cognitive deficits in a mouse model of Alzheimer’s disease – J Xu – 2014
- Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer’s disease mouse model – Y Zhang – 2010
- Drug reverses brain deficits of Alzheimer’s in mouse model – Yale University – 2014
- Further evidence that controlling high blood pressure can reduce dementia, Alzheimer’s risk – 2019
- Blood Pressure and Dementia – a Comprehensive Review – SP Kennelly – 2009
- How the brain’s immune system could be harnessed to improve memory – RMIT University – 2020
- Alzheimer’s wake-up call – 2017
- Effects of phosphatidylserine in Alzheimer’s disease – T Crook – 2017
- Effect of Phosphatidylserine on Cerebral Glucose Metabolism in Alzheimer’s Disease – P Klinkhammer – 1990
- Efficacy of vinpotropile in the therapy of initial signs of cerebrovascular pathology – 2010
- Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial – C Calabrese – 2008
